Loading drug development pipeline…
Loading drug development pipeline…
Derived
For each drug, the most advanced stage supported by registered interventional trials and jurisdiction-aware approval records. Approval in any ingested jurisdiction outranks trial phase; a drug is counted once, at its highest stage.
Computedci-drug-pipeline-v1Stage rulesApprovals feed →
Funnel
Drugs reach Non-Hodgkin Lymphoma through trial conditions or approval indications mapped to it or to one of its descendant entities.
45 drugs · 284 active trials
27 drugs · 479 active trials
56 drugs · 2,316 active trials
Outside the funnel: Phase not stated 1 · Withdrawn 1. "Withdrawn" = every approval record for the scope is withdrawn or superseded; "phase not stated" = trials exist but none states a phase.
Data updated 19 hours agoSource updated unknownrecomputed with the intelligence layer
Drugs
Most advanced stage first, then most active trials. Trial counts are interventional studies linking the drug (and, when a cancer is selected, the cancer).
| Drug | Stage | Max phase | Active | Recruiting | Phase 3 | Total trials | Approvals | Jurisdictions | First approval | First trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Panobinostat | Approved | Phase 3 | 0 | 0 | 1 | 43 | 1 | EU | Aug 28, 2015 | Mar 1, 2003 |
| Ibritumomab Tiuxetan | Approved | Phase 4 | 0 | 0 | 6 | 19 | 2 | EU, US | Feb 19, 2002 | 2001-08 |
| Melphalan Flufenamide | Approved | Phase 3 | 0 | 0 | 2 | 6 | 1 | EU | Aug 17, 2022 | Dec 28, 2016 |
| Mechlorethamine | Approved | Phase 2 | 0 | 0 | 0 | 5 | 1 | US | Aug 23, 2013 | 2007-07 |
| Chlormethine | Approved | N/A | 0 | 0 | 0 | 1 | 1 | EU | Mar 3, 2017 | Dec 7, 2021 |
| Vorasidenib | Approved | — | 0 | 0 | 0 | 0 | 2 | EU, US | Aug 6, 2024 | — |
| Fludarabine | Phase 4 | Phase 4 | 91 | 50 | 24 | 335 | 0 | — | — | 1994-01 |
| Prednisone | Phase 4 | Phase 4 | 89 | 34 | 57 | 238 | 0 | — | — | 1993-03 |
| Vincristine | Phase 4 | Phase 4 | 85 | 36 | 63 | 244 | 0 | — | — | 1993-03 |
| Etoposide | Phase 4 | Phase 4 | 48 | 20 | 30 | 200 | 0 | — | — | 1993-03 |
| Cytarabine | Phase 4 | Phase 4 | 35 | 16 | 21 | 124 | 0 | — | — | 1993-03 |
| Gemcitabine | Phase 4 | Phase 4 | 24 | 9 | 22 | 94 | 0 | — | — | 2003-03 |
| Ifosfamide | Phase 4 | Phase 4 | 15 | 7 | 7 | 49 | 0 | — | — | 2002-07 |
| Mercaptopurine | Phase 4 | Phase 4 | 11 | 8 | 8 | 25 | 0 | — | — | 1993-03 |
| Axicabtagene Ciloleucel | Phase 4 | Phase 4 | 11 | 9 | 3 | 22 | 0 | — | — | Apr 21, 2015 |
| Busulfan | Phase 4 | Phase 4 | 10 | 5 | 6 | 71 | 0 | — | — | 1988-03 |
| Pegfilgrastim | Phase 4 | Phase 4 | 9 | 4 | 4 | 34 | 0 | — | — | 2002-06 |
| Cisplatin | Phase 4 | Phase 4 | 8 | 2 | 7 | 38 | 0 | — | — | 1998-06 |
| Mogamulizumab | Phase 4 | Phase 4 | 7 | 6 | 1 | 22 | 0 | — | — | 2007-02 |
| Daunorubicin | Phase 4 | Phase 4 | 7 | 6 | 5 | 16 | 0 | — | — | 1993-03 |
| Dasatinib | Phase 4 | Phase 4 | 6 | 4 | 0 | 20 | 0 | — | — | Sep 17, 2007 |
| Thioguanine | Phase 4 | Phase 4 | 6 | 4 | 6 | 15 | 0 | — | — | 2004-04 |
| Decitabine | Phase 4 | Phase 4 | 4 | 2 | 2 | 18 | 0 | — | — | 2004-02 |
| Chemotherapy | Phase 4 | Phase 4 | 3 | 2 | 4 | 15 | 0 | — | — | 1997-09 |
| Vindesine | Phase 4 | Phase 4 | 3 | 2 | 5 | 11 | 0 | — | — | 2004-04 |
| Idelalisib | Phase 4 | Phase 4 | 2 | 1 | 4 | 30 | 0 | — | — | 2008-06 |
| Zoledronic Acid | Phase 4 | Phase 4 | 1 | 1 | 5 | 21 | 0 | — | — | 1998-12 |
| Temsirolimus | Phase 4 | Phase 4 | 1 | 1 | 1 | 16 | 0 | — | — | 2002-04 |
| Asparaginase | Phase 4 | Phase 4 | 1 | 0 | 2 | 12 | 0 | — | — | 1993-03 |
| Epirubicin | Phase 4 | Phase 4 | 1 | 1 | 2 | 11 | 0 | — | — | 2002-06 |
| R-CHOP Regimen | Phase 4 | Phase 4 | 1 | 1 | 0 | 2 | 0 | — | — | Jul 1, 2017 |
| CHOP Regimen | Phase 4 | Phase 4 | 0 | 0 | 0 | 4 | 0 | — | — | 2011-08 |
| Interferon Alfa-2b | Phase 4 | Phase 4 | 0 | 0 | 0 | 2 | 0 | — | — | Jun 1, 2014 |
| Venetoclax | Phase 3 | Phase 3 | 87 | 39 | 15 | 166 | 0 | — | — | Jul 11, 2007 |
| Oxaliplatin | Phase 3 | Phase 3 | 20 | 7 | 14 | 42 | 0 | — | — | 2000-09 |
| Nivolumab | Phase 3 | Phase 3 | 17 | 3 | 3 | 68 | 0 | — | — | Aug 2, 2012 |
| Azacitidine | Phase 3 | Phase 3 | 16 | 11 | 3 | 43 | 0 | — | — | Mar 3, 2006 |
| Carboplatin | Phase 3 | Phase 3 | 14 | 6 | 5 | 45 | 0 | — | — | 2003-08 |
| Pegaspargase | Phase 3 | Phase 3 | 11 | 4 | 13 | 39 | 0 | — | — | Sep 12, 2006 |
| Odronextamab | Phase 3 | Phase 3 | 10 | 7 | 5 | 10 | 0 | — | — | Nov 13, 2019 |
| Duvelisib | Phase 3 | Phase 3 | 9 | 5 | 4 | 29 | 0 | — | — | 2013-05 |
| Copanlisib | Phase 3 | Phase 3 | 8 | 0 | 3 | 32 | 0 | — | — | Nov 19, 2012 |
| Blinatumomab | Phase 3 | Phase 3 | 8 | 4 | 3 | 18 | 0 | — | — | 2004-06 |
| Trametinib | Phase 3 | Phase 3 | 8 | 2 | 1 | 11 | 0 | — | — | Oct 30, 2013 |
| Filgrastim | Phase 3 | Phase 3 | 7 | 3 | 10 | 93 | 0 | — | — | 1995-05 |
| Calaspargase Pegol | Phase 3 | Phase 3 | 7 | 4 | 3 | 8 | 0 | — | — | Jun 19, 2017 |
| Carmustine | Phase 3 | Phase 3 | 6 | 3 | 8 | 49 | 0 | — | — | 1994-01 |
| Sirolimus | Phase 3 | Phase 3 | 6 | 2 | 2 | 36 | 0 | — | — | 2002-07 |
| Lisocabtagene Maraleucel | Phase 3 | Phase 3 | 6 | 3 | 1 | 15 | 0 | — | — | Nov 27, 2017 |
| Leucovorin | Phase 3 | Phase 3 | 5 | 2 | 5 | 23 | 0 | — | — | 2000-02 |
Stages describe registered activity and ingested regulatory records, not efficacy. Only ingested jurisdictions (currently US and Canada) can place a drug at "approved"; trial phases are as registered by sponsors. Nothing here is a treatment recommendation.